Axa S.A. Emergent Bio Solutions Inc. Transaction History

Axa S.A.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$33.11 - $55.01 $311,234 - $517,094	-9,400 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$81.91 - $134.94 $769,954 - $1.27 Million	9,400 New	9,400 $971,000
Q2 2020 Aug 14, 2020	SELL	$54.33 - $89.52 $277,083 - $456,552	-5,100 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$49.34 - $68.76 $251,634 - $350,676	5,100 New	5,100 $295,000
Q4 2018 Feb 13, 2019	SELL	$55.63 - $73.24 $356,032 - $468,735	-6,400 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$52.05 - $66.51 $374,760 - $478,872	-7,200 Reduced 52.94%	6,400 $421,000
Q1 2018 May 14, 2018	SELL	$44.44 - $54.39 $559,944 - $685,314	-12,600 Reduced 48.09%	13,600 $716,000
Q4 2017 Feb 13, 2018	SELL	$37.77 - $47.75 $3.43 Million - $4.34 Million	-90,900 Reduced 77.63%	26,200 $1.22 Million
Q3 2017 Nov 13, 2017	BUY	$34.14 - $40.45 $4 Million - $4.74 Million	117,100	117,100 $4.74 Million

162

33.2M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $522M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.